BDBM284767 US10023575, Example 58::US10023575, Example 92a::US10023575, Example 92b::US10023575, Example 93a::US10023575, Example 93b::US10479794, Example 93b::US10875867, Example 58::US11691977, Example 58

SMILES Cc1cnc2c(cnn2c1)C(=O)NC1(COCC1(C)O)c1ccc(cc1F)C(F)(F)F

InChI Key InChIKey=TVEAFXBHWJGOGR-UHFFFAOYSA-N

Data  24 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 284767   

TargetcAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM284767(US10023575, Example 58 | US10023575, Example 92a |...)
Affinity DataIC50: >1.00E+4nMAssay Description:Assay Principle: The PDE reaction cleaves cAMP to AMP. The IMAP system (Molecular Device) using fluorescence polarization (FP) as detection principle...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcGMP-dependent 3',5'-cyclic phosphodiesterase(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM284767(US10023575, Example 58 | US10023575, Example 92a |...)
Affinity DataIC50:  14nMAssay Description:Assay Principle: The PDE reaction cleaves cAMP to AMP. The IMAP system (Molecular Device) using fluorescence polarization (FP) as detection principle...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent